Interactions between Non-Physician Clinicians and Industry: A Systematic Review

In a systematic review of studies of interactions between non-physician clinicians and industry, Quinn Grundy and colleagues found that many of the issues identified for physicians' industry interactions exist for non-physician clinicians. Please see later in the article for the Editors' Summary

[1]  A. Jutel,et al.  Soft Targets: Nurses and the Pharmaceutical Industry , 2008, PLoS medicine.

[2]  Ruth E Malone,et al.  Distal nursing. , 2003, Social science & medicine.

[3]  C. Schroeder.  The Tyranny of Profit: Concentration of Wealth, Corporate Globalization, and the Failed US Health Care System , 2003, ANS. Advances in nursing science.

[4]  C. Wright,et al.  Who's keeping the code? Compliance with the international code for the marketing of breast-milk substitutes in Greater Glasgow , 2007, Public Health Nutrition.

[5]  Lisa A Bero,et al.  Attitudes of academic and clinical researchers toward financial ties in research: A systematic review , 2005, Science and engineering ethics.

[6]  N. Crigger,et al.  Nurse practitioners' perceptions and participation in pharmaceutical marketing. , 2009, Journal of advanced nursing.

[7]  D. Auerbach,et al.  Will the NP Workforce Grow in the Future?: New Forecasts and Implications for Healthcare Delivery , 2012, Medical care.

[8]  Jason Hall,et al.  The information sources used by community nurse prescribers. , 2003, British journal of nursing.

[9]  N. Crigger.  Towards understanding the nature of conflict of interest and its application to the discipline of nursing. , 2009, Nursing philosophy : an international journal for healthcare professionals.

[10]  Ethics of pharmaceutical company relationships with the nursing profession: No free lunch….and no more pens? , 2009, Contemporary nurse.

[11]  N. Freudenberg.  Public Health Advocacy to Change Corporate Practices: Implications for Health Education Practice and Research , 2005, Health education & behavior : the official publication of the Society for Public Health Education.

[12]  B. Crabtree,et al.  The value of pharmaceutical representative visits and medication samples in community-based family practices. , 2000, The Journal of family practice.

[13]  A. Figueiras,et al.  Influence of commercial information on prescription quantity in primary care. , 2002, European journal of public health.

[14]  I. Kerridge,et al.  Empirical uncertainty and moral contest: a qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia. , 2006, Social science & medicine.

[15]  A. Jutel,et al.  Nurses' reported influence on the prescription and use of medication. , 2010, International nursing review.

[16]  Monitoring compliance with the International Code of Marketing of Breastmilk Substitutes in west Africa: multisite cross sectional survey in Togo and Burkina Faso , 2003, BMJ : British Medical Journal.

[17]  Hyla H. Polen,et al.  Nurse prescribers' interactions with and perceptions of pharmaceutical sales representatives. , 2009, Journal of clinical nursing.

[18]  M. Brezis,et al.  Vulnerability of Health to Market Forces , 2011, Medical care.

[19]  T. Cymet,et al.  The Truth about Drug Companies: How They Deceive Us and What to Do about It , 2006 .

[20]  A. Clarke,et al.  Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine , 2003, American Sociological Review.

[21]  Joann L. Baril,et al.  Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting? , 2009, Journal of General Internal Medicine.

[22]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[23]  M. Dixon-Woods,et al.  The problem of appraising qualitative research. , 2004 .

[24]  Charles D MacLean,et al.  The Effect of Medication Samples on Self-Reported Prescribing Practices: A Statewide, Cross-Sectional Survey , 2010, Journal of General Internal Medicine.

[25]  P. Adams.  Assessing whether to receive funding support from tobacco, alcohol, gambling and other dangerous consumption industries. , 2007, Addiction.

[26]  B. Philipp,et al.  Distribution of industry-sponsored diaper bags from maternity facilities in Massachusetts. , 2007, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[27]  Pharmacists' perceptions of the pharmaceutical industry. , 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[28]  N. Crigger.  Pharmaceutical promotions and conflict of interest in nurse practitioner's decision making: The undiscovered country , 2005, Journal of the American Academy of Nurse Practitioners.

[29]  D. Mahoney,et al.  "Under the radar": nurse practitioner prescribers and pharmaceutical industry promotions. , 2010, The American journal of managed care.

[30]  A. Jutel,et al.  “But Doctors do it…”: Nurses' Views of Gifts and Information from the Pharmaceutical Industry , 2009, The Annals of pharmacotherapy.

[31]  P. Nolan,et al.  Nurse prescribing: the experiences of psychiatric nurses in the United States. , 2004, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[32]  G. Hastings.  Why corporate power is a public health priority , 2012, BMJ : British Medical Journal.

[33]  D. Mahoney,et al.  More than a prescriber: gerontological nurse practitioners' perspectives on prescribing and pharmaceutical marketing. , 2010, Geriatric nursing.

[34]  D. Bates,et al.  Why pharmacists belong in the medical home. , 2010, Health affairs.

[35]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[36]  G. Loewenstein,et al.  A social science perspective on gifts to physicians from industry. , 2003, JAMA.

[37]  W. Austin.  The incommensurability of nursing as a practice and the customer service model: an evolutionary threat to the discipline. , 2011, Nursing philosophy : an international journal for healthcare professionals.

[38]  Kalman D. Applbaum.  `Consumers are Patients!' Shared Decision-making and Treatment Non-compliance as Business Opportunity , 2009, Transcultural psychiatry.

[39]  Joseph Dumit,et al.  Drugs for Life: How Pharmaceutical Companies Define Our Health , 2012 .

[40]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[41]  J. Cantrill,et al.  How do district nurses choose which products to prescribe? , 2009, British journal of community nursing.

[42]  Sowmya R. Rao,et al.  Physician professionalism and changes in physician-industry relationships from 2004 to 2009. , 2010, Archives of internal medicine.

[43]  A. Wazana.  Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift? , 2000 .

[44]  E. Schneller,et al.  Hip and knee implants: current trends and policy considerations. , 2008, Health affairs.

[45]  P. Nolan,et al.  Supplementary nurse prescribing. , 2004, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[46]  W. Wiist.  Comprar The Bottom Line or Public Health Tactics Corporations Use to Influence Health and Health Policy, and What We Can Do to Counter Them | William H. Wiist | 9780195375633 | Oxford University Press , 2010 .

[47]  Mark Engel,et al.  Conducting a meta-ethnography of qualitative literature: Lessons learnt , 2008, BMC medical research methodology.